ProtoKinetix

ProtoKinetix Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of ProtoKinetix (PKTX) as of Nov 19, 2026 is 34.39 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 61.28 % — a change of -43.88% (lower).

Cash Conversion

34.39 %

YoY

-43.88%

Last updated:

Cash Conversion Rate (OCF/Net Income) of ProtoKinetix is 2025 34.39 % . Cash Conversion Rate (OCF/Net Income) of ProtoKinetix was 2024 61.28 % . It decreases by -43.88% lower compared to the previous year.

The ProtoKinetix Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
37.28 USD
Jan 1, 2019
20.26 USD
Jan 1, 2020
11.53 USD
Jan 1, 2021
38.21 USD
Jan 1, 2022
42.20 USD
Jan 1, 2023
90.60 USD
Jan 1, 2024
61.28 USD
Jan 1, 2025
34.39 USD
The ProtoKinetix Cash Conversion history
YEARCash ConversionYoY
34.39 %-43.88%
61.28 %-32.36%
90.60 %+114.71%
42.20 %+10.43%
38.21 %+231.41%
11.53 %-43.10%
20.26 %-45.65%
37.28 %-6.74%
39.98 %-25.69%
53.80 %+17.56%
45.76 %-66.46%
136.46 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ProtoKinetix Stock analysis

What does ProtoKinetix do? ProtoKinetix Inc. is a Canadian biotechnology company focused on the development of glycoproteins for therapeutic applications. The company was founded in 2005 and is headquartered in Marietta, USA. ProtoKinetix specializes in the research and development of AAGP® (Anti-Aging Glycopeptide) as biopharmaceuticals. These proprietary glycoproteins have the ability to protect cells and can be used in various therapeutic applications for improving damage in physical injury, spinal cord injury, diabetes, transplantation, and retinal diseases. In addition to the medical field, ProtoKinetix is also developing its patented technology for use in bio-agriculture and animal healthcare. It has a subsidiary that holds the rights to use and distribute AAGP® and its patents. ProtoKinetix's business model involves licensing its glycoprotein technology for various applications, including biopharmaceuticals, bioprocessing industries, and cell protection management for regenerative medicine and stem cell preparations. The company has established partnerships with other biotech companies to integrate its AAGP® technology into their product pipelines. ProtoKinetix's flagship product is the AAGP® protein solution, which is used as a medication in regenerative medicine, organ transplantation, eye healing, and animal health. It is also interested in researching the application of AAGP® in crop farming to increase yields and improve soil quality. ProtoKinetix is poised to play a significant role in the development of glycoproteins as future medicines and therapeutic technologies in various industries. It not only has the potential to explore healing medical products but also aims to enhance agriculture and animal care. ProtoKinetix represents an excellent example of a biotechnology company focused on improving the healthcare and agricultural industries. ProtoKinetix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ProtoKinetix stock

Cash Conversion Rate (OCF/Net Income) of ProtoKinetix is 34.39 % in 2025.

Cash Conversion Rate (OCF/Net Income) of ProtoKinetix changed from 61.28 % to 34.39 %, representing a -43.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) ProtoKinetix since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s ProtoKinetix with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — ProtoKinetix

All Key Metrics — ProtoKinetix